Table 1. In vitro activity of 5, 9, 12a–12aa against Mycobacterium tuberculosis H37Rv in various assays and media and an Mtb cytochrome bd oxidase mutant cydKO.
MIC (μM) |
|||||
Entry | Compound | H37Rv MABA 2 week a | H37Rv 1 week b | H37Rv 2 week c | cydKO 2 week d |
1 | 5 | 1.11 | 2.21 | 53.92 | 0.14 |
2 | 9 | 2.32 | 3.57 | >148 | 0.59 |
3 | 12a | 0.62 | 1.21 | >155 | 0.12 |
4 | 12b | 6.53 | 141.88 | >142 | 0.57 |
5 | 12c | 1.11 | 2.21 | >142 | 0.14 |
6 | 12d | 2.04 | 24.58 | 32.69 | 0.18 |
7 | 12e | 24.58 | >131 | >131 | 3.14 |
8 | 12f | 24.58 | >131 | >131 | 2.04 |
9 | 12g | 2.13 | 4.26 | >136 | 0.19 |
10 | 12h | >125 | 92.20 | >125 | 0.37 |
11 | 12i | 1.94 | >125 | >125 | 0.17 |
12 | 12j | 0.56 | 26.35 | 53.25 | <0.067 |
13 | 12k | 3.36 | 103.70 | >140 | 0.20 |
14 | 12l | 0.45 | 0.45 | >149 | <0.071 |
15 | 12m | 1.51 | >125 | >125 | 0.12 |
16 | 12n | 0.53 | 0.53 | 24.71 | <0.063 |
17 | 12o | 54.22 | 142.69 | >143 | 4.45 |
18 | 12p | 60.90 | 121.80 | >122 | 7.62 |
19 | 12q | 122.00 | >122 | >122 | 90.13 |
20 | 12r | 31.69 | ≧127 | >127 | 3.04 |
21 | 12s | 25.79 | 68.59 | 68.59 | 2.14 |
22 | 12t | 121.55 | >164 | >164 | 41.06 |
23 | 12u | >176 | >176 | >176 | 21.98 |
24 | 12v | 19.75 | 158.03 | 158.03 | 0.95 |
25 | 12w | >78 | 38.77 | >155 | 7.13 |
26 | 12x | 9.30 | 56.48 | >74 | 0.45 |
27 | 12y | 103.70 | 26.35 | >140 | 1.09 |
28 | 12z | >125 | 23.42 | >125 | 0.50 |
29 | 12aa | >128 | >128 | >128 | >128 |
PAS e | 0.3 | 0.3 | 0.6 | 0.6 | |
Linezolid e | 2.3 | 2.3 | 2.3 | 1.56 | |
3 e | 1.56 | 12.5 | >25 | 0.31 |
aMIC against H37Rv grown in 7H9/ADC/Tween media. MIC determination using microplate Alamar Blue assay (MABA) after 2 weeks post compound addition.
bMIC against H37Rv grown in 7H9/ADC/Tween media. MIC determination after 1 week post compound addition.
cMIC against H37Rv grown in 7H9/ADC/Tween media. MIC determination after 2 weeks post compound addition.
dMIC against cyd knock-out strain of H37Rv grown in 7H9/ADC/Tween media. MIC determination after 2 weeks post-compound addition.
eLinezolid, PAS (p-aminosalicylic acid) and 3 were used as positive controls.